Detrunorm 15mg Tablet
PDF Leaflet Revision Date: 7 April 2006
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of urinary incontinence and urgency in unstable bladder conditions.
Dosage (summary)
Adults: 15 mg (1 tablet) twice daily, may increase to 3 times daily. Elderly: No special regimen.
Special Populations
- Elderly
- Renal impairment
- Hepatic disorders
Pregnancy & Breastfeeding
Contra-indicated during pregnancy and lactation.
Key Drug Interactions
- Tricyclic antidepressants
- Benzodiazepines
- Anticholinergics
- Cholinergic medicines
Contraindications
- Hypersensitivity
- Bowel obstruction
- Bladder outflow obstruction
- Myasthenia gravis
- Glaucoma
- Hepatic disorders
- Renal impairment
Common side effects
- Dry mouth
- Constipation
- Blurred vision
- Drowsiness
Counselling Points
- May cause drowsiness
- Avoid operating machinery
- Report any severe side effects
Serious warnings
- Monitor hepatic enzymes
- Risk of glaucoma
- Caution in autonomic neuropathy
Important Disclaimer
The Detrunorm 15mg Tablet professional information leaflet below is the property of Litha Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
